Injection statement implied disease treatment linkage, NAD rules The NAD press release said the company, which is based in San Antonio, TX, failed to provide sufficient evidence to support the claims made on the product
Boutari, C
however, in contrast to the previously partially purified onion GGT (Lancaster and Shaw, 1994), the purified AcGGT protein showed high affinity for glutathione and glutathione S -conjugates but could not utilize -glutamyl- trans - S -1-propenyl-L-cysteine sulfoxide as a good -glutamyl donor substrate, suggesting that AcGGT is not the major enzyme catalyzing deglutamylation in the biosynthesis of S -alk(en)yl-L-cysteine sulfoxides in onion (Shaw et al., 2005)
"Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis"
Some peptides, mainly those not FDA-approved, may be obtained from compounding pharmacies or unverified sources
BPC-157 (as Arginate Salt)